PERSPECTIVES OF TIGECYCLINE TREATMENT OF SURGICAL SITE INFECTIONS IN ONCOLOGIC PATIENTS
Criteria of tigecycline (Tygacil) use for the treatment surgical infections in oncologic in patients were developed. High efficacy of tigecycline in vitro and in vivo against multiresistant hospital strains persistent in the surgical department of the gastrointestinal oncologic division.
Saved in:
Main Authors: | S. D. Mitrokhin, A. A. Sokolov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2020-05-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/430 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SUCCESSFUL TREATMENT OF PERIPROSTHESIS INFECTION BY TIGECYCLINE
by: S. K. Yarovoy, et al.
Published: (2015-04-01) -
The effect of renal replacement therapy on the concentration of tigecycline in the blood in patients with sepsis-associated acute kidney injury
by: A. V. Marukhov, et al.
Published: (2024-02-01) -
ADEQUATE EMPIRIC THERAPY OF NOSOCOMIAL FUNGAL INFECTIONS IN ONCOLOGICAL PATIENTS IN THE INTENSIVE CARE UNITS
by: S. D. Mitrokhin, et al.
Published: (2020-05-01) -
Modern Antifungals in Therapy of Nosocomial Mycosis in Oncologic Patients
by: S. D. Mitrokhin, et al.
Published: (2020-05-01) -
Tigecycline therapy for multidrug-resistant bacteria: is it the right choice for pediatric patients
by: Gulhadiye Avcu, et al.
Published: (2025-07-01)